Agreed @RhinoInvestor - I had already sold ARB out of my SMSF, as I said, and then I liquidated that other portfolio in June, and did not buy back into ARB in July, as I see them as fairly to fully valued at $40 or above, so as good as they are, and they are a very good company, I think there are better priced oportunities elsewhere at this point, however in terms of high quality companies, ones I do NOT hold currently in real money portfolios but would likely buy back into if they became substantially cheaper include ARB, WES, TNE and XRF. There are others that just aren't on the tip of my tongue at the minute.

I did buy $80K worth of LYL on Friday in a few different trades so as not to move the breadcrumb trades too much - all at under $13.90 - as I want to lock in that full year dividend and the upside when they report. If they drop down below $13, I'll buy more. At their current elevated levels, Lycopodium is still on a market beating fully franked dividend yield and are not expensive - I wanted to buy them at lower levels but realistically they're not even at fair value yet when I break it down, so why quibble?

I also increased my GNG (GR Engineering) position, however they could reduce their own full year dividend or even suspend it altogether on the back of their largest EPC contract, West Musgrave being mothballed by BHP which GNG say is going to reduce their revenue by circa $80m in the current (FY2025) financial year, and GNG are majority owned by their management, founders, and founders' families, and tend to be very conservative, so it's quite possible that they'll not match their previous full year dividend, but will make it up to shareholders later when they have more work.

LYL, on the other hand, I expect to increase their full year dividend once again, even if only by 1 cent/share, because they're flying, and they are likely to get even more work in Africa and elsewhere the way things are going. I think GNG are well positioned to pick up some decent EPC contracts here in Australia for clients where they have done studies (PFS, DFS) and also where the studies have been done by others who do not do construction. But the market has gone cold on GNG on the back of West Musgrave being shelved, and that's totally understandable, however I see it as an opportunity to buy them while they're down (for under $2/share). With LYL I may not get the same opportunity.